Background: Activins are novel therapeutic targets in pulmonary arterial hypertension (PAH).
We therefore studied whether key members of the activin pathway could be used as PAH …

Rationale The blood is a rich source of potential biomarkers for the diagnosis of idiopathic
and hereditary pulmonary arterial hypertension (iPAH and hPAH, referred to as “PAH”) …

Background Risk stratification and assessment of disease progression in patients with
pulmonary arterial hypertension (PAH) are challenged by the lack of accurate disease …

Red cell distribution width (RDW) is an easy-to-access marker which is routinely measured
in complete blood count (CBC) test. Besides the classic use of RDW as a marker for …

Background Clinical significance of red blood cell distribution (RDW) as a predictive marker
for the incidence of postoperative morbidity after esophagectomy for esophageal cancer has …

There is a lack of an effective prognostic model for predicting outcomes in patients with
primary pulmonary hypertension (PPH). A retrospective analysis was conducted on PPH …

Background Pulmonary hypertension (PH) is one of the common complications in chronic
obstructive pulmonary disease (COPD). The study aimed to evaluate the predicting ability of …

Background Exploration of whether circRNAs in the skin of systemic sclerosis (SSc) model
mice interact with 4E-BP1 protein to mediate the mTOR signaling pathway to regulate SSc …

Systemic sclerosis (SSc) is an immuno-inflammatory rheumatic disease that can affect both
the skin and internal organs through fibrosis. Pulmonary arterial hypertension (PAH) is one …

The pathogenesis of SSc pulmonary fibrosis is complex and prognosis is poor. In order to
find biomarkers to provide assistance in the diagnosis and treatment of systemic sclerosis …